Cargando…
Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834034/ https://www.ncbi.nlm.nih.gov/pubmed/28407031 http://dx.doi.org/10.1093/annonc/mdx170 |
| _version_ | 1783303583411732480 |
|---|---|
| author | Chin, K. Chand, V. K. Nuyten, D. S. A. |
| author_facet | Chin, K. Chand, V. K. Nuyten, D. S. A. |
| author_sort | Chin, K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5834034 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58340342018-03-07 Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy Chin, K. Chand, V. K. Nuyten, D. S. A. Ann Oncol Industry Corner: Perspectives and Controversies Oxford University Press 2017-07 2017-04-12 /pmc/articles/PMC5834034/ /pubmed/28407031 http://dx.doi.org/10.1093/annonc/mdx170 Text en © The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Industry Corner: Perspectives and Controversies Chin, K. Chand, V. K. Nuyten, D. S. A. Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy |
| title | Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy |
| title_full | Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy |
| title_fullStr | Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy |
| title_full_unstemmed | Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy |
| title_short | Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy |
| title_sort | avelumab: clinical trial innovation and collaboration to advance anti-pd-l1 immunotherapy |
| topic | Industry Corner: Perspectives and Controversies |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834034/ https://www.ncbi.nlm.nih.gov/pubmed/28407031 http://dx.doi.org/10.1093/annonc/mdx170 |
| work_keys_str_mv | AT chink avelumabclinicaltrialinnovationandcollaborationtoadvanceantipdl1immunotherapy AT chandvk avelumabclinicaltrialinnovationandcollaborationtoadvanceantipdl1immunotherapy AT nuytendsa avelumabclinicaltrialinnovationandcollaborationtoadvanceantipdl1immunotherapy |